Healthcare Triangle, Inc. reported a significant revenue increase to $28.2 million for the nine months ended September 30, 2026, compared to $10.8 million in the prior year, driven by business expansion. However, the company continues to operate at a loss, with a net loss from operations of $9.7 million for the period and a total asset base that grew to $72.7 million following substantial increases in intangible assets.
Healthcare Triangle, Inc. effected a 1-for-20 reverse stock split of its common stock effective October 26, 2026. The action reduced the number of outstanding shares from approximately 17.7 million to 886,587 to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
Healthcare Triangle stockholders approved a proposal to authorize the Board of Directors to effect one or more reverse stock splits at a ratio ranging from 1-for-2 to 1-for-25. Additionally, shareholders approved an amendment to the 2020 Stock Incentive Plan and authorized potential share issuances exceeding 20% of outstanding stock at below-market prices for Nasdaq compliance purposes.